The one destination for all the information and resources you may need to help your patients start and stay on TREMFYA®

The work you do every day makes it possible for patients to start and stay on therapy. This site was designed to organize the most important tools and resources needed to support you in this work.


*"Preferred" means TREMFYA® can be accessed first-line (ie, step therapy is not required) and its formulary status is better than or equivalent to other products in the class.

These percentages may not represent 100% of formulary lives due to data limitations.

When you choose TREMFYA®, different patient-support programs may help patients get TREMFYA®, depending on their coverage. Patients with government insurance may not have coverage for TREMFYA®. Learn more about specific patient-support programs and eligibility requirements.

Collected in 01/22 and subject to change. This information does not provide advice or guarantee coverage or payment. Legal requirements and plan information can be updated frequently. We strongly recommend contacting the plan for more information about current coverage, restrictions, or prerequisites that may apply.

Reference: 1. Data provided by Managed Markets Insight and Technology, LLC™, a trademark of MMIT, as of January 2022.



TREMFYA® access has improved for 2022—see where it has preferred first-line access without biologic step edits* by entering a ZIP code below.



Janssen Link offers eligible patients TREMFYA® at no cost until their commercial insurance covers the medication. See program requirements at JanssenCarePath.com/Tremfya/Janssen-Link.

*Requiring no step edits indicates a drug will be given first-line biologic access and will not require stepping through other biologic therapies.

The information provided is not a guarantee of coverage or payment (partial or full). Actual benefits are determined by each plan administrator in accordance with its respective policy and procedures. This document is presented for informational purposes only and is not intended to provide reimbursement or legal advice, nor does it promise or guarantee coverage, levels of reimbursement, payment, or charge. It is not intended to increase or maximize reimbursement by any payer. Laws, regulations, and policies concerning reimbursement are complex and are updated frequently. While we have made an effort to be current as of the issue date of this document, the information may not be as current or comprehensive when you view it. Please refer to the applicable plan’s website, or contact the plan for more information about coverage or any restrictions or prerequisites that may apply. We strongly recommend you consult the payer organization for its reimbursement policies. All information is subject to change. Nothing herein may be construed as an endorsement, approval, recommendation, representation, or warranty of any kind by any plan or insurer referenced herein. This communication is solely the responsibility of Janssen Biotech, Inc.


Complete the registration form below to receive the latest updates from BioCoordiNATION® as well as important information to support the treatment of your patients.

The information you provide will only be used by Janssen Biotech, Inc., our affiliates, and our service providers to send you information about TREMFYA® key resources and tools and to fulfill other requests you may select. You may unsubscribe here or by following the instructions in the messages you receive. Our Privacy Policy further governs the use of the information you provide. By providing the information and selecting the “SUBMIT” button, you indicate you read, understand, and agree to these terms.

*Fields Required.